Novavax, Inc. (NVAX)
9.42
+0.12
(+1.29%)
USD |
NASDAQ |
Sep 11, 16:00
9.40
-0.02
(-0.21%)
After-Hours: 07:15
Novavax Price : 9.42 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 9.29 | 9.865 | 9.23 | 9.42 | 6.121M |
| Sep 10, 2026 | 9.64 | 9.68 | 9.11 | 9.30 | 5.893M |
| Sep 09, 2026 | 10.02 | 10.24 | 9.73 | 9.85 | 4.444M |
| Sep 08, 2026 | 10.10 | 10.36 | 9.75 | 10.19 | 4.231M |
| Sep 04, 2026 | 10.50 | 10.75 | 10.04 | 10.22 | 5.125M |
| Sep 03, 2026 | 10.42 | 10.48 | 9.900 | 10.34 | 6.227M |
| Sep 02, 2026 | 10.28 | 10.73 | 9.96 | 10.32 | 5.636M |
| Sep 01, 2026 | 9.20 | 10.26 | 9.19 | 10.12 | 10.04M |
| Aug 31, 2026 | 9.10 | 9.985 | 9.09 | 9.37 | 7.272M |
| Aug 28, 2026 | 9.18 | 9.34 | 8.89 | 9.26 | 4.212M |
| Aug 27, 2026 | 9.12 | 9.18 | 8.915 | 9.05 | 3.427M |
| Aug 26, 2026 | 9.33 | 9.44 | 9.13 | 9.21 | 3.515M |
| Aug 25, 2026 | 9.07 | 9.58 | 8.93 | 9.44 | 7.108M |
| Aug 24, 2026 | 8.87 | 8.98 | 8.26 | 8.86 | 5.579M |
| Aug 21, 2026 | 8.44 | 9.200 | 8.435 | 8.94 | 10.45M |
| Aug 20, 2026 | 8.50 | 8.66 | 8.02 | 8.42 | 5.976M |
| Aug 19, 2026 | 8.43 | 8.83 | 8.19 | 8.79 | 11.45M |
| Aug 18, 2026 | 7.97 | 8.08 | 7.835 | 7.93 | 2.015M |
| Aug 17, 2026 | 8.05 | 8.17 | 7.95 | 8.07 | 1.928M |
| Aug 14, 2026 | 8.13 | 8.13 | 7.915 | 8.05 | 2.280M |
| Aug 13, 2026 | 8.01 | 8.23 | 7.92 | 8.14 | 3.507M |
| Aug 12, 2026 | 7.91 | 7.99 | 7.83 | 7.96 | 2.542M |
| Aug 11, 2026 | 7.92 | 8.03 | 7.78 | 7.95 | 2.607M |
| Aug 10, 2026 | 7.892 | 7.96 | 7.695 | 7.89 | 3.225M |
| Aug 07, 2026 | 7.75 | 8.086 | 7.595 | 7.95 | 5.704M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 143.97 |
| Merck & Co., Inc. | 143.93 |
| Pfizer Inc. | 27.72 |
| Recursion Pharmaceuticals, Inc. | 3.20 |
| Agenus, Inc. | 6.94 |
Price Related Metrics
| PS Ratio | 3.730 |
| Earnings Yield | -16.17% |
| Market Cap | 1.553B |